NADPH oxidase inhibitor diphenyleneiodonium induces p53 expression and cell cycle arrest in several cancer cell lines |
Jo, Hong-Jae
(Department of General Surgery, Pusan National University School of Medicine)
Kim, Kang-Mi (Department of Microbiology & Immunology and Medical Research Institute, Pusan National University School of Medicine) Song, Ju-Dong (Department of Microbiology & Immunology and Medical Research Institute, Pusan National University School of Medicine) Park, Young-Chul (Department of Microbiology & Immunology and Medical Research Institute, Pusan National University School of Medicine) |
1 | Pandian, R. P., V. K. Kutala, A. Liaugminas, N. L. Parinandi and P. Kuppusamy. 2005. Lipopolysaccharideinduced alterations in oxygen consumption and radical generation in endothelial cells. Mol. Cell. Biochem. 278, 119-127-172 |
2 | Riganti, C., E. Gazzano, M. Polimeni, C. Costamagna, A. Bosia and D. Ghigo. 2004. Diphenyleneiodonium inhibits the cell redox metabolism and induces oxidative stress. J. Biol. Chem. 279, 47726-47731 DOI ScienceOn |
3 | Sanders, S. A., R. Eisenthal and R. Harrison. 1997. NADH oxidase activity of human xanthine oxidoreductase--generation of superoxide anion. Eur. J. Biochem. 245, 541-548 DOI ScienceOn |
4 | Scaife, R.M. (2005) Selective and irreversible cell cycle inhibition by diphenyleneiodonium. Mol. Cancer Ther. 4, 876-884 DOI ScienceOn |
5 | Shuto, M., K. Ogita and Y. Yoneda. 1997. Protection by diphenyliodonium against glutamate neurotoxicity due to blocking of N-methyl-D-aspartate receptors. Neurochem. Int. 31, 73-82 DOI ScienceOn |
6 | Stuehr, D. J., O. A. Fasehun, N. S. Kwon, S. S. Gross, J. A. Gonzalez, R. Levi and C. F. Nathan. 1991. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J. 5, 98-103 DOI |
7 | Tew, D. G. 1993. Inhibition of cytochrome P450 reductase by the diphenyliodonium cation. Kinetic analysis and covalent modifications. Biochemistry 32, 10209-10215 DOI ScienceOn |
8 | Wang, X. W., Q. Zhan, J. D. Coursen, M. A. Khan, H. U. Kontny, L. Yu, M. C. Hollander, P. M. O'Connor, A. J. Fornace and C. C. Harris. 1999. GADD45 induction of a G2/M cell cycle checkpoint. Proc. Natl. Acad. Sci. USA 96, 3706-3711 DOI |
9 | Weir, E. K., C. N. Wyatt, H. L. Reeve, J. Huang, S. L. Archer and C. Peers. 1994. Diphenyleneiodonium inhibits both potassium and calcium currents in isolated pulmonary artery smooth muscle cells. J. Appl. Physiol. 76, 2611-2615 DOI |
10 | Ianzini, F., A. Bertoldo, E. A. Kosmacek, S. L. Phillips and M. A. Mackey. 2006. Lack of p53 function promotes radiation- induced mitotic catastrophe in mouse embryonic fibroblast cells. Cancer Cell Int. 6, 11 (p1-8) DOI ScienceOn |
11 | Li, N., K. Ragheb, G. Lawler, J. Sturgis, B. Rajwa, J. A. Melendez and J. P. Robinson. 2003. DPI induces mitochondrial superoxide-mediated apoptosis. Free Radic. Biol. Med. 34, 465-477 DOI ScienceOn |
12 | Li, Y. and M. A. Trush. 1998. Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun. 253, 295-299 DOI ScienceOn |
13 | Maya, R., M. Balass, S. T. Kim, D. Shkedy, J. F. Leal, O. Shifman, M. Moas, T. Buschmann, Z. Ronai, Y. Shiloh, M. B. Kastan, E. Katzir and M. Oren. 2001. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15, 1067-1077. DOI ScienceOn |
14 | Meng, L. H., H. Zhang, L. Hayward, H. Takemura, R. G. Shao and Y. Pommier. 2004. Tetrandrine induces early arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of -S-specific cyclin-dependent kinases and by inducing p53 and . Cancer Res. 64, 9086-9092 DOI ScienceOn |
15 | Park, B. S., Y. S. Song, S. B. Yee, B. G. Lee, S. Y. Seo, Y. C. Park, J. M. Kim, H. M. Kim and Y. H. Yoo. 2005. Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis. Apoptosis 10, 193-200 DOI ScienceOn |
16 | Nakamura, Y., K. Tsuji, M. Shuto, K. Ogita, Y. Yoneda, K. Shimamoto, T. Shibata and K. Kataoka. 1997. Protection by diphenyliodonium against glutamate neurotoxicity due to blocking of N-methyl-D-aspartate receptors. Neuroscience 76, 459-466 DOI ScienceOn |
17 | O'Donnell, V. B., D. G. Tew, O. T. Jones and P. J. England. 1993. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem. J. 290, 41-49 DOI |
18 | Ormerod, M. G. 1990. pp. 69-81, Flow cytometry: A practical approach, Oxford University Press, New York |
19 | Chen, Y., Z. H. Miao, W. M. Zhao and J. Ding. 2005. The p53 pathway is synergized by p38 MAPK signaling to mediate 11,11'-dideoxyverticillin-induced arrest. FEBS Lett. 579, 3683-3690 DOI ScienceOn |
20 | Cross, A. R. and O. T. Jones. 1986. The effect of the inhibitor diphenylene iodonium on the superoxide-generating sys tem of neutrophils. Specific labelling of a component polypeptide of the oxidase. Biochem. J. 237, 111-116 DOI |
21 | Flatt, P. M., L. J. Tang, C. D. Scatena, S. T. Szak and J. A. Pietenpol. 2000. p53 regulation of checkpoint is retinoblastoma protein dependent. Mol. Cell. Biol. 20, 4210- 4223 DOI ScienceOn |
22 | Doussiere, J., J. Gaillard and P. V. Vignais. 1999. The heme component of the neutrophil NADPH oxidase complex is a target for aryliodonium compounds. Biochemistry 38, 3694-3703 DOI ScienceOn |
23 | Eastman, A. 2004. Cell cycle checkpoints and their impact on anticancer therapeutic strategies. J. Cell. Biochem. 91, 223-231 DOI ScienceOn |
24 | Finkel, T. 2000. Redox-dependent signal transduction. FEBS Lett. 476, 52-54 DOI ScienceOn |
25 | Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 |